Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01070069 · ClinicalTrials.gov registry record · NA
Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial
A NA study, sponsored by Endologix.
- Completed
- Registry status
- NA
- Development phase
- 192
- Enrollment target
NCT01070069 is a NA study that has completed, run by Endologix. The registered enrollment target is 192 participants.
The verdict
NCT01070069, a NA study, has completed, sponsored by Endologix.
- COMPLETED
- Registry status
- NA
- Development phase
- 192 participants
- Enrollment target
Study Summary
To determine the safety and effectiveness of PEVAR.
Interventions
- DEVICE PEVAR (ProGlide closure)
- DEVICE SEVAR (IntuiTrak)
- DEVICE PEVAR (Prostar XL closure)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2010-04-13 |
| Est. Completion | 2012-09-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01070069
The ClinicalTrials.gov registry entry for NCT01070069 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endologix, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PEVAR (ProGlide closure) is the first listed.
NCT01070069 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01070069 about?
NCT01070069 is a clinical study titled "Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial". To determine the safety and effectiveness of PEVAR.
What is the current status of trial NCT01070069?
This trial is currently completed. It is a NA study. The enrollment target is 192 participants. The study started on 2010-04-13. Estimated completion is 2012-09-05.
What interventions are being tested in trial NCT01070069?
The interventions under investigation include: PEVAR (ProGlide closure) (DEVICE), SEVAR (IntuiTrak) (DEVICE), PEVAR (Prostar XL closure) (DEVICE).
Who is sponsoring clinical trial NCT01070069?
This trial is sponsored by Endologix, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.